EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.62 | (16alpa,17beta)-16-(3-bromopropyl)estra-1(10),2,4-triene-3,17-diol | EM-251 | Homo sapiens | |
1.1.1.62 | (3-amino-5-[13-[(16beta,17beta)-3,17-dihydroxyestra-1(10),2,4-trien-16-yl]tridecyl]phenyl)acetic acid | - |
Homo sapiens | |
1.1.1.62 | (3-[(4-aminophenyl)carbonyl]-5-[13-[(16beta,17beta)-3,17-dihydroxyestra-1(10),2,4-trien-16-yl]tridecyl]phenyl)acetic acid | - |
Homo sapiens | |
1.1.1.62 | (3-[13-[(16beta,17beta)-3,17-dihydroxyestra-1(10),2,4-trien-16-yl]tridecyl]phenyl)acetic acid | - |
Homo sapiens | |
1.1.1.62 | 5'-O-[9-[(16beta,17beta)-3,17-dihydroxyestra-1(10),2,4-trien-16-yl]nonanoyl]adenosine | EM-1745, bisubstrate inhibitor of 17beta-HSD1 | Homo sapiens | |
1.1.1.62 | EM-1745 | bisubstrate inhibitor of 17beta-HSD1 | Homo sapiens | |
1.1.1.62 | N-butyl-6-[[(6beta,17beta)-3,17-dihydroxyestra-1(10),2,4-trien-6-yl]oxy]-N-methylhexanamide | - |
Homo sapiens | |
1.1.1.62 | N-butyl-6-[[(6beta,17beta)-3,17-dihydroxyestra-1(10),2,4-trien-6-yl]sulfanyl]-N-methylhexanamide | EM-678 | Homo sapiens | |
1.1.1.62 | N-butyl-7-[(6beta,17beta)-3,17-dihydroxyestra-1(10),2,4-trien-6-yl]-N-methylheptanamide | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.62 | Homo sapiens | P14061 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.62 | dehydroepiandrosterone + NAD(P)H | - |
Homo sapiens | androst-5-ene-3beta,17beta-diol + NAD(P)+ | - |
? | |
1.1.1.62 | estradiol-17beta + NAD(P)+ | - |
Homo sapiens | estrone + NAD(P)H + H+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.62 | 17beta-HSD1 | - |
Homo sapiens |
1.1.1.62 | type 1 17beta-hydroxysteroid dehydrogenase | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.62 | NAD(P)+ | - |
Homo sapiens |